Anti-Ro-52 was correlated with pulmonary disorders in dermatomyositis, whereas Anti-Jo-1 was correlated with pulmonary alterations in polymyositis. Clinics, 2013 July; 68(7): 909–914. (Also see: Dermatomyositis and Polymyositis and Autoantibodies)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.